2023 Q3 Form 10-Q Financial Statement

#000141057823002029 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $323.6K $295.0K
YoY Change 15.76% 30.94%
Cost Of Revenue $72.44K $62.52K
YoY Change 24.87% 37.9%
Gross Profit $251.2K $232.4K
YoY Change 13.38% 29.19%
Gross Profit Margin 77.62% 78.8%
Selling, General & Admin $490.2K $573.8K
YoY Change -12.29% 23.89%
% of Gross Profit 195.16% 246.88%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit 0.0% 0.0%
Operating Expenses $490.2K $573.8K
YoY Change -12.29% 23.89%
Operating Profit -$239.0K -$341.4K
YoY Change -29.15% 20.53%
Interest Expense $162.1K $284.5K
YoY Change 0.97% 108.46%
% of Operating Profit
Other Income/Expense, Net -$137.7K -$1.118M
YoY Change -77.81% 342.64%
Pretax Income -$376.7K -$1.460M
YoY Change -60.67% 172.39%
Income Tax
% Of Pretax Income
Net Earnings -$376.7K -$1.460M
YoY Change -60.67% 172.39%
Net Earnings / Revenue -116.41% -494.93%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 471.5M 309.7M
Diluted Shares Outstanding 466.2M 335.0M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $138.5K $416.3K
YoY Change -69.82% 538.14%
Cash & Equivalents $138.5K $416.3K
Short-Term Investments
Other Short-Term Assets $264.0K $326.8K
YoY Change 160.92% 986.44%
Inventory $131.3K $113.2K
Prepaid Expenses
Receivables $9.200K $25.79K
Other Receivables $0.00 $0.00
Total Short-Term Assets $543.0K $882.0K
YoY Change -21.8% 212.6%
LONG-TERM ASSETS
Property, Plant & Equipment $149.7K $149.7K
YoY Change -78.94% -79.1%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $310.4K $149.7K
YoY Change -56.34% -79.1%
TOTAL ASSETS
Total Short-Term Assets $543.0K $882.0K
Total Long-Term Assets $310.4K $149.7K
Total Assets $853.4K $1.032M
YoY Change -39.27% 3.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $277.7K $269.5K
YoY Change 0.23% -4.14%
Accrued Expenses $786.7K $663.6K
YoY Change 9.62% 171.82%
Deferred Revenue $130.1K $237.7K
YoY Change 403.48% 161.59%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.394M $1.413M
YoY Change -1.54% 43.25%
Total Short-Term Liabilities $3.091M $3.154M
YoY Change 24.68% 91.91%
LONG-TERM LIABILITIES
Long-Term Debt $150.0K $150.0K
YoY Change -76.96% -77.23%
Other Long-Term Liabilities $9.174K $9.998K
YoY Change -16.94% -1.67%
Total Long-Term Liabilities $9.174K $9.998K
YoY Change -16.94% -1.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.091M $3.154M
Total Long-Term Liabilities $9.174K $9.998K
Total Liabilities $3.369M $3.314M
YoY Change 7.27% 43.31%
SHAREHOLDERS EQUITY
Retained Earnings -$27.12M -$26.74M
YoY Change 13.14% 16.32%
Common Stock $4.713K $4.323K
YoY Change 198.86% 204.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.516M -$2.282M
YoY Change
Total Liabilities & Shareholders Equity $853.4K $1.032M
YoY Change -39.27% 3.32%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$376.7K -$1.460M
YoY Change -60.67% 172.39%
Depreciation, Depletion And Amortization $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Operating Activities -$277.8K -$635.9K
YoY Change -14.39% 549.44%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $149.7K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 -$149.7K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -33.14K
YoY Change -100.0% 380.29%
NET CHANGE
Cash From Operating Activities -277.8K -635.9K
Cash From Investing Activities 0.000 -149.7K
Cash From Financing Activities 0.000 -33.14K
Net Change In Cash -277.8K -818.8K
YoY Change -170.56% 681.13%
FREE CASH FLOW
Cash From Operating Activities -$277.8K -$635.9K
Capital Expenditures $0.00 $149.7K
Free Cash Flow -$277.8K -$785.6K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
335001567
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114596514
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
288045553
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105976603
dei Entity Central Index Key
EntityCentralIndexKey
0001715819
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
Electromedical Technologies, Inc
dei Security Exchange Name
SecurityExchangeName
NONE
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://electromedtech.com/20230630#ChangeInFairValueOfDerivativeLiabilities
elcq Standard Warranty Period
StandardWarrantyPeriod
P3Y
us-gaap Fair Value Recurring Basis Unobservable Input Reconciliation Liability Gain Loss Statement Of Income Extensible List
FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfIncomeExtensibleList
http://electromedtech.com/20230630#ChangeInFairValueOfDerivativeLiabilities
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56192
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-2619815
dei Entity Address Address Line1
EntityAddressAddressLine1
16561 N. 92nd Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 101
dei Entity Address City Or Town
EntityAddressCityOrTown
Scottsdale
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85260
dei City Area Code
CityAreaCode
888
dei Local Phone Number
LocalPhoneNumber
880-7888
dei Security12g Title
Security12gTitle
Common Stock
dei Trading Symbol
TradingSymbol
EMED
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
25788
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
471495857
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
416256
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
368425
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9444
CY2023Q2 us-gaap Inventory Net
InventoryNet
113151
CY2022Q4 us-gaap Inventory Net
InventoryNet
62061
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
326801
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
207872
CY2023Q2 us-gaap Assets Current
AssetsCurrent
881996
CY2022Q4 us-gaap Assets Current
AssetsCurrent
647802
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
149705
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
705469
CY2023Q2 us-gaap Assets
Assets
1031701
CY2022Q4 us-gaap Assets
Assets
1353271
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
269498
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
266744
CY2023Q2 elcq Credit Cards Payable
CreditCardsPayable
20769
CY2022Q4 elcq Credit Cards Payable
CreditCardsPayable
37633
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
663604
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1065483
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
237650
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
217588
CY2023Q2 elcq Discount On Convertible Promissory Notes Current
DiscountOnConvertiblePromissoryNotesCurrent
0
CY2022Q4 elcq Discount On Convertible Promissory Notes Current
DiscountOnConvertiblePromissoryNotesCurrent
375865
CY2023Q2 elcq Convertible Promissory Notes Payable Current
ConvertiblePromissoryNotesPayableCurrent
1412601
CY2022Q4 elcq Convertible Promissory Notes Payable Current
ConvertiblePromissoryNotesPayableCurrent
1304909
CY2022Q4 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
31818
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
549604
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3153726
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2924175
CY2022Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
489707
CY2023Q2 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
150000
CY2022Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
150000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
9998
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
10234
CY2023Q2 us-gaap Liabilities
Liabilities
3313724
CY2022Q4 us-gaap Liabilities
Liabilities
3574116
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1999000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
999000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
432493896
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
189784529
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
4323
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1896
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23693025
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22237300
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26744371
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-24825041
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2282023
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2220845
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1031701
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1353271
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
294954
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
225251
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
673600
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
447145
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
62519
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
45335
us-gaap Cost Of Revenue
CostOfRevenue
150215
us-gaap Cost Of Revenue
CostOfRevenue
112976
CY2023Q2 us-gaap Gross Profit
GrossProfit
232435
CY2022Q2 us-gaap Gross Profit
GrossProfit
179916
us-gaap Gross Profit
GrossProfit
523385
us-gaap Gross Profit
GrossProfit
334169
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
573838
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
463179
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2126326
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1342989
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-341403
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-283263
us-gaap Operating Income Loss
OperatingIncomeLoss
-1602941
us-gaap Operating Income Loss
OperatingIncomeLoss
-1008820
CY2023Q2 us-gaap Interest Expense
InterestExpense
284487
CY2022Q2 us-gaap Interest Expense
InterestExpense
136468
us-gaap Interest Expense
InterestExpense
672688
us-gaap Interest Expense
InterestExpense
349847
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1193676
CY2023Q2 elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
126958
elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
126958
CY2023Q2 us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
366958
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
366958
CY2023Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
340000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
340000
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-116200
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-321800
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1118403
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-252668
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-312928
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-671647
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1459806
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-535931
us-gaap Net Income Loss
NetIncomeLoss
-1915869
us-gaap Net Income Loss
NetIncomeLoss
-1680467
CY2023Q2 elcq Deemed Dividend Related To Warrant Resets
DeemedDividendRelatedToWarrantResets
3461
elcq Deemed Dividend Related To Warrant Resets
DeemedDividendRelatedToWarrantResets
3461
elcq Deemed Dividend Related To Warrant Resets
DeemedDividendRelatedToWarrantResets
63381
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1463267
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-535931
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1919330
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1743848
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335001567
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
335001567
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
114596514
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114596514
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
288045553
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
288045553
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
105976603
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
105976603
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.02
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2220845
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
315000
CY2023Q1 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
400000
CY2023Q1 elcq Share Issued During Period Values In Conjunction Settlement Reset
ShareIssuedDuringPeriodValuesInConjunctionSettlementReset
698000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
160000
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
50000
CY2023Q1 elcq Share Issued During Period Values In Settlement Of Stock Based Compensation Liabilities
ShareIssuedDuringPeriodValuesInSettlementOfStockBasedCompensationLiabilities
21000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-456063
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1032908
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
210691
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1459806
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-2282023
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-722503
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
356900
CY2022Q1 elcq Adjustments To Additional Paid In Capital Warrants Issued In Conjunction With Convertible Promissory Notes
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithConvertiblePromissoryNotes
142996
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
42766
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4703
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1144536
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-1699029
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45000
CY2022Q2 elcq Stock Issued During Period Value In Conjunction Forbearance Of Convertible Debt
StockIssuedDuringPeriodValueInConjunctionForbearanceOfConvertibleDebt
142800
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
668370
CY2022Q2 elcq Adjustments To Additional Paid In Capital Warrants Issued In Conjunction With Debt Extinguishment
AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebtExtinguishment
65000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-535931
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-1313790
us-gaap Profit Loss
ProfitLoss
-1915869
us-gaap Profit Loss
ProfitLoss
-1680467
us-gaap Share Based Compensation
ShareBasedCompensation
715000
us-gaap Share Based Compensation
ShareBasedCompensation
406603
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4557
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10938
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-321800
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
535865
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
254585
elcq Change In Fair Value Of Derivative Liabilities
ChangeInFairValueOfDerivativeLiabilities
126958
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
366958
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1193676
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
11875
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16344
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-7797
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
51090
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-58955
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
118929
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-7927
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2754
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
66348
elcq Increase Decrease In Credit Card Payables
IncreaseDecreaseInCreditCardPayables
-16864
elcq Increase Decrease In Credit Card Payables
IncreaseDecreaseInCreditCardPayables
29784
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
440077
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
8114
elcq Increase Decrease In Customer Deposits Operating Activities
IncreaseDecreaseInCustomerDepositsOperatingActivities
20062
elcq Increase Decrease In Customer Deposits Operating Activities
IncreaseDecreaseInCustomerDepositsOperatingActivities
90850
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
1001
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1088666
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-415765
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
149705
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1894588
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1744883
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
522401
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
13787
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-57875
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
494220
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
85985
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
367500
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
42766
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-608386
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
97824
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
47831
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-317941
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
368425
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
383170
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
416256
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65229
us-gaap Interest Paid Net
InterestPaidNet
31574
us-gaap Interest Paid Net
InterestPaidNet
79402
elcq Adoption Of Accounting Standard
AdoptionOfAccountingStandard
379355
elcq Warrants And Common Stock Feature Issued In Conjunction With Convertible Promissory Note
WarrantsAndCommonStockFeatureIssuedInConjunctionWithConvertiblePromissoryNote
350796
elcq Settlement Of Stock Based Compensation Liabilities
SettlementOfStockBasedCompensationLiabilities
719000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
260691
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
668370
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
237650
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
217588
elcq Initial Warranty Period
InitialWarrantyPeriod
P3Y
CY2023Q2 us-gaap Deferred Income
DeferredIncome
22468
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of certain assets and liabilities, certain disclosures at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Significant estimates affecting the financial statements have been prepared on the basis of the most current and best available information. However, actual results from the resolution of such estimates and assumptions may vary from those used in the preparation of the financial statements.</p>
elcq Accumulated Net Loss
AccumulatedNetLoss
23000000.0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1088666
elcq Working Capital Deficit
WorkingCapitalDeficit
2271730
elcq Right Of Return Period
RightOfReturnPeriod
P30D
elcq Sales Returns Allowance
SalesReturnsAllowance
6990
CY2022 elcq Sales Returns Allowance
SalesReturnsAllowance
6990
CY2022Q4 us-gaap Deferred Income
DeferredIncome
23313
CY2023Q2 us-gaap Receivables From Customers
ReceivablesFromCustomers
19442
CY2022Q4 us-gaap Receivables From Customers
ReceivablesFromCustomers
13342
CY2023Q2 us-gaap Due From Customer Acceptances
DueFromCustomerAcceptances
7560
CY2022Q4 us-gaap Due From Customer Acceptances
DueFromCustomerAcceptances
0
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
132950
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
77025
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
491846
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
69200
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
126958
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
549604
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
549604
CY2023Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
549604
CY2023Q2 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
61000
CY2022Q4 us-gaap Sales And Excise Tax Payable Current And Noncurrent
SalesAndExciseTaxPayableCurrentAndNoncurrent
61000
CY2023Q2 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
16779
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12678
elcq Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Outstanding Warrants Stock Options And Convertible Promissory Notes
IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfOutstandingWarrantsStockOptionsAndConvertiblePromissoryNotes
1633797033
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
174692
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
899987
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
24987
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
194518
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
149705
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
705469
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1193676
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5469
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4557
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10938
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1412601
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1680774
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
375865
CY2023Q2 us-gaap Notes Payable
NotesPayable
1412601
CY2022Q4 us-gaap Notes Payable
NotesPayable
1304909
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1412601
CY2023Q2 us-gaap Notes Payable
NotesPayable
1412601
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1680774
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
375865
CY2022Q4 us-gaap Notes Payable
NotesPayable
1304909
CY2021Q4 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
81678
CY2022Q1 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
47941
CY2022Q3 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
821461
CY2022Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
0
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Issues
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues
491846
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
69200
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
126958
CY2023Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
549604
us-gaap Compensation Expense Excluding Cost Of Good And Service Sold
CompensationExpenseExcludingCostOfGoodAndServiceSold
400000
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
2000000
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12000
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
50000000
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P10Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2023Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
25000000
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
160000
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
28837533
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
27837533
elcq Adjustments To Additional Paid In Capital Warrants Reset
AdjustmentsToAdditionalPaidInCapitalWarrantsReset
3461
elcq Commitment For Product Development
CommitmentForProductDevelopment
300000
elcq Amount For Commitment For Product Development Paid
AmountForCommitmentForProductDevelopmentPaid
150000
elcq Expected Milestone Term
ExpectedMilestoneTerm
P12M
CY2023Q2 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
0
CY2023Q2 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
5000
us-gaap Loss Contingency Number Of Plaintiffs
LossContingencyNumberOfPlaintiffs
3
CY2023Q2 us-gaap Loss Contingency Estimate Of Possible Loss
LossContingencyEstimateOfPossibleLoss
5000

Files In Submission

Name View Source Status
0001410578-23-002029-index-headers.html Edgar Link pending
0001410578-23-002029-index.html Edgar Link pending
0001410578-23-002029.txt Edgar Link pending
0001410578-23-002029-xbrl.zip Edgar Link pending
elcq-20230630.xsd Edgar Link pending
elcq-20230630x10q.htm Edgar Link pending
elcq-20230630x10q001.jpg Edgar Link pending
elcq-20230630xex31d1.htm Edgar Link pending
elcq-20230630xex31d2.htm Edgar Link pending
elcq-20230630xex32d1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
elcq-20230630_cal.xml Edgar Link unprocessable
elcq-20230630_pre.xml Edgar Link unprocessable
elcq-20230630_def.xml Edgar Link unprocessable
elcq-20230630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
elcq-20230630x10q_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending